test

James Silverman

@Opaleye Management Inc.

Latest period2024 - Q3ReportedManaged Assets$599.558MTotal holdings44
Assets growth rate37%Assets growth rate (2-Q avg)16.19%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Opaleye Management Inc.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 44 positions.

Assets under management

The assets under management (AUM) of Opaleye Management Inc. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 599.558M in assets, with a quarterly growth rate of 37% and a 2-quarter average growth rate of 16.19%. The portfolio is managed by James Silverman, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
XOMAXoma Corp Del
Recent Activity
1.11%
$6.62M
250,000 shares@ $26.48 avg price
NUVLNuvalent Inc
Recent Activity
Increased 7.93%
1.1%
$6.547M
64,000 shares@ $102.3 avg price
NAMSNewamsterdam Pharma Company
Recent Activity
Increased 6.35%
0.93%
$5.561M
335,000 shares@ $16.6 avg price
URGNUrogen Pharma Ltd
Recent Activity
Decreased -1.91%
0.86%
$5.132M
404,100 shares@ $12.7 avg price
PTGXProtagonist Therapeutics Inc
Recent Activity
0.79%
$4.725M
105,000 shares@ $45.0 avg price
3834⤦Gossamer Bio Inc
Recent Activity
0.7%
$4.189M
8M shares@ $0.53 avg price
CYTKCytokinetics Inc
Recent Activity
Decreased -62.06%
0.67%
$3.976M
75,300 shares@ $52.8 avg price
4857⤦Karyopharm Therapeutics Inc
Recent Activity
0.67%
$3.961M
6M shares@ $0.67 avg price
GOSSGossamer Bio Inc
Recent Activity
Decreased -6.26%
0.62%
$3.706M
3.665M shares@ $1.02 avg price
ZNTLZentalis Pharmaceuticals Inc
Recent Activity
New Position
0.6%
$3.559M
967,000 shares@ $3.68 avg price